Shesh Rai

29PUBLICATIONS

82CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jul 01, 2026

Factors Associated With Optimal Patient-Clinician Communication Among Cancer Survivors.

|Jun 25, 2026

A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.

|Jun 23, 2026

Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity.

|Aug 06, 2025

Potassium channels mediate the inhibitory effect of exosomes on anti-tumor immunity in head and neck cancer.

Ameet A Chimote, Abdulaziz O Alshwimi, Simran Venkatraman

|May 16, 2025

Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Olga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz

|Sep 27, 2024

Disparities in Clinical Trial Participation: A Cross-Sectional Survey of Cancer Patients at a Midwest Academic Medical Center.

Katie Moreland, Melinda Butsch Kovacic, Shesh Rai

Pageof 5

Frequent Collaborators

Samarendra Das

Trisha Wise-Draper

Jianmin Pan

Audrey Romano

Olga Zamulko

Farrukh Aqil

Allie Forsythe

Casey L Allen

Ilaina Monroe

Maria Lehn

Frequent Collaborators

Samarendra Das

Trisha Wise-Draper

Jianmin Pan

Audrey Romano